Article in Arquivos de neuro-psiquiatria, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
25 authors.
Alfredo DamascenoUniversidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Neurologia, Campinas SP, Brazil.ORCID 0000-0002-7919-3989
Cintia RamariUniversity of Hasselt, Rehabilitation Research Center (REVAL), Faculty of Rehabilitation Sciences, Hasselt, Belgium.ORCID 0000-0002-9405-5437
Henry Koiti SatoInstituto Neurológico de Curitiba, Departamento de Neuroimunologia, Curitiba PR, Brazil.ORCID 0000-0002-5582-1792
Dagoberto CallegaroUniversidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, São Paulo SP, Brazil.ORCID 0000-0003-0077-173X
Maria Fernanda MendesFaculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo SP, Brazil.ORCID 0000-0003-3983-6019
José Artur Costa D'AlmeidaHospital Geral de Fortaleza, Departamento de Neurologia, Fortaleza CE, Brazil.ORCID 0000-0002-6627-6515
Denise Sisterolli DinizHospital Geral de Goiás, Departamento de Neurologia, Goiânia GO, Brazil.ORCID 0000-0002-3078-6804
Osvaldo J M NascimentoHospital Universitário Antônio Pedro, Departamento de Neurologia, Fortaleza CE, Brazil.ORCID 0000-0003-3516-485X
Laura ParolinNeurovie Neurologia e Saúde, Departamento de Neurologia, Joinville SC, Brazil.ORCID 0009-0001-7229-7144
Thiago FukudaUniversidade Federal da Bahia, Faculdade de Medicina da Bahia, Departamento de Neurologia e Psiquiatria, Salvador BA, Brazil.ORCID 0000-0002-7718-4288
Paulo GamaPontifícia Universidade Católica de São Paulo, Faculdade de Ciências Médicas e da Saúde, Departamento de Neurologia, Sorocaba SP, Brazil.ORCID 0000-0003-2585-1074
Herval Soares NetoHospital do Servidor Estadual de São Paulo, Departamento de Neuroimunologia, São Paulo SP, Brazil.ORCID 0000-0002-1694-0457
Marco Lana-PeixotoUniversidade Federal de Minas Gerais, Centro de Investigação de Esclerose Múltipla, Belo Horizonte MG, Brazil.ORCID 0000-0003-2454-681X
Giordani Rodrigues Dos PassosPontifícia Universidade Católica do Rio Grande do Sul, Hospital São Lucas, Porto Alegre RS, Brazil.ORCID 0000-0002-8949-6115
Rayllene CaetanoPontifícia Universidade Católica do Rio Grande do Sul, Hospital São Lucas, Porto Alegre RS, Brazil.ORCID 0009-0003-7806-8881
Caio César Diniz DisserolInstituto Neurológico de Curitiba, Departamento de Neuroimunologia, Curitiba PR, Brazil.ORCID 0000-0001-7568-0897
Gabriel de Deus VieiraUniversidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Neurologia, Campinas SP, Brazil.ORCID 0000-0001-8644-4937
Guilherme Diogo SilvaUniversidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, São Paulo SP, Brazil.ORCID 0000-0001-9764-3763
Eliana CunhaFaculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo SP, Brazil.ORCID 0000-0002-3040-9865
Natália TalimUniversidade Federal de Minas Gerais, Centro de Investigação de Esclerose Múltipla, Belo Horizonte MG, Brazil.ORCID 0000-0002-2664-6534
Mario B WagnerUniversidade Federal do Rio Grande do Sul, Faculdade de Medicina, Departamento de Medicina Social, Porto Alegre RS, Brazil.ORCID 0000-0002-3661-4851
Milena Sales PitombeiraHospital Geral de Fortaleza, Departamento de Neurologia, Fortaleza CE, Brazil.ORCID 0000-0002-3298-0264
Jefferson BeckerPontifícia Universidade Católica do Rio Grande do Sul, Hospital São Lucas, Porto Alegre RS, Brazil.ORCID 0000-0002-9981-3620
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Multiple sclerosis (MS) is an inflammatory and neurodegenerative disorder whose prevalence varies across Brazil (from 15-27 cases per 100 thousand inhabitants), and the absence of an extensive national study limits the understanding of MS epidemiology in a nation as diverse as Brazil.To compare epidemiological data, including healthcare access, among people with MS across four Brazilian regions.Data from 2,974 Brazilian MS patients in the Collaborative Latin American Database for Multiple Sclerosis (BRANDO) were analyzed. We assessed demographic and clinical outcomes, as well as healthcare access, to elucidate regional differences.The cohort was predominantly composed of female patients (72.5%) with MS onset at a mean age of 30.6 years. Regarding the regional differences, there was a lower predominance of female patients (68.7%;
Indexed as
Health Services AccessibilityMultiple SclerosisAdolescentAdultBrazilDatabases, FactualFemaleHumansMaleMiddle AgedPrevalenceSex DistributionYoung Adult
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Epidemiology and healthcare access in Brazilian multiple sclerosis patients: insights from the BRANDO database. · full record | OpenQuestion